Cipla | CIPLA - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Arca Biopharma USD 504K 246K 2024-09
aTyr Pharma 79.65M 78.89M 2026-03
Bio Path 677K 547K 2026-03
Capricor Therapeutics 3.05M 2.46M 2025-12
Cara Therapeutics -89.64M 128.67M 2025-12
Cipla INR 131.3M 9M 2026-03
Dr.Reddys Laboratories INR 1.06B 113M 2026-03
Esperion Therapeutics USD 22.64M 585K 2025-12
Immunic 197K 222K 2025-12
Minerva Neurosciences USD 2.31M 60K 2024-06
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Sangamo BioSciences 97.56M 11.39M 2025-06
Sun Pharmaceuticals INR 998.6M 250.6M 2025-09
TherapeuticsMD USD 20K 25K 2023-09
UPL INR 7.74B 210M 2025-12